Viralex is an immunomodulatory agent with broad-spectrum antiviral properties. It enhances both innate & adaptive immunity and strengthens the body's defence response to viral infections
The company, already scaling across Europe, plans to accelerate the deployment of its medication reconciliation platform in the United States
Achieving ML 4 brings Singapore closer to becoming a WHO listed authority, a new scheme that will be operational later this year and will list the world’s regulators of reference
This policy will ensure multi-disciplinary collaboration, promote start-up culture and develop an innovation-led ecosystem at medical institutes across the country
Dr. Shah will lead strategic and operational clinical development of the company's diverse pipeline
The companies plan to use the proceeds to retire debt and expand operations
The device will facilitate the treatment of cerebral vasospasm following hemorrhagic stroke
The KRIVIDA Novus RT-PCR kit can detect the Omicron variant, its sub-lineages, and the Delta variant in 45 minutes
It has a total of 50 ANDA approvals from USFDA
Companies plan to commercialize breath-based detection of lung infection and transplant rejection
Subscribe To Our Newsletter & Stay Updated
